|
🐜
|
Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
10 auth.
J. Hey-Hadavi,
A. Pleil,
L. Deeb,
J. Fuqua,
L. Silverman,
B. Reiner,
...
R. Newfield,
N. Rajicic,
M. Wajnrajch,
J. Cara
|
4 |
2010 |
4
🐜
|
|
🐜
|
Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Growth Factor-1 and Growth Hormone Sufficiency: Results from a Randomized, Multicenter, Open-Label, Parallel-Group, Active Treatment-Controlled Trial
8 auth.
P. Backeljauw,
B. Miller,
P. Dutailly,
A. Houchard,
Elizabeth Lawson,
D. Hale,
...
B. Reiner,
M. Sperling
|
4 |
2015 |
4
🐜
|
|
🐜
|
A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting
8 auth.
L. Deeb,
H. Dulude,
C. B. Guzman,
Shuyu Zhang,
B. Reiner,
Claude A. Piché,
...
Sheetal Pradhan,
Xiaotian M Zhang
|
3 |
2018 |
3
🐜
|
|
🐬
|
Human plasma‐derived alpha1‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study
William H. Lagarde,
K. Courtney,
B. Reiner,
Kimberly Steinmann,
E. Tsalikian,
S. Willi
|
3 |
2020 |
3
🐬
|
|
🐬
|
Studies in Modified Ad Libitum Feeding of Premature Infants 1
H. Keitel,
B. Reiner,
R. Ting
|
2 |
1962 |
2
🐬
|
|
🐬
|
OR14,83 rhGH/rhIGF-1 co-administration versus rhGH alone in short, prepubertal children with low IGF-1 and normal stimulated GH levels: first-year results from a Phase II, randomized, open-label, active-treatment controlled trial
L. Midyett,
B. Reiner,
J. Frane,
G. Bright
|
2 |
2010 |
2
🐬
|
